Therapeutic Goods (Standard for Medicinal Cannabis) (TGO 93) Order 2017
11Adulteration
Start here
Get a plain-English read of 11
Turn the raw legal text into a practical explanation grounded in Therapeutic Goods (Standard for Medicinal Cannabis) (TGO 93) Order 2017.
11 Adulteration
(1) Medicinal cannabis products and any ingredients used in the manufacture of those products, including, but not limited to, the cannabis plant, must not contain any substance that results in the adulteration of those products or ingredients.
(2) For the purposes of subsection (1), adulteration includes the addition of, or substitution with, any substance that is extraneous to the formulation of the product, other than a processing aid.
(3) In determining whether adulteration has occurred, it is irrelevant whether or not the addition or substitution is intended to improve, fortify or debase the medicinal cannabis product or any ingredients used in the manufacture of that product, including, but not limited to, the cannabis plant.